gross revenue1 of $28.75 million, up 37 percent on the same period last year. Bubs® Infant Formula was the key driver of growth with attributable gross revenues up 77 percent compared to the prior corresponding period (pcp). Revenue of adult goat milk powder have also increased 30 percent over the same period.
still an EBITDA loss of $3.74
looks like they have a bright future, just a bit worried what this EBITDA loss will do to the stock price today... even though its because they are spending more to make the company grow.
gross revenue1 of $28.75 million, up 37 percent on the same...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
18.0¢ |
Change
0.010(5.88%) |
Mkt cap ! $160.7M | |||
| Open | High | Low | Value | Volume |
| 17.5¢ | 18.0¢ | 17.0¢ | $228.5K | 1.302M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 480569 | 17.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 18.0¢ | 1053754 | 20 |
View Market Depth
| Last trade - 16.20pm 30/06/2025 (20 minute delay) ? |
| BUB (ASX) Chart |